(Q48712930)

14 February 2018

title

Management of behavioral and psychiatric problems in Parkinson's disease. (English)

1 reference

14 February 2018

author name string

Rabinstein AA

series ordinal

1

1 reference

14 February 2018

Shulman LM

series ordinal

2

1 reference

14 February 2018

publication date

1 November 2000

1 reference

14 February 2018

number of pages

10

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

14 February 2018

volume

7

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

41-50

1 reference

14 February 2018

Depression and Parkinson's disease: a review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Anxiety and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Fatigue in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Sleep disorder related to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

How common is dementia in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Psychiatric symptoms in Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Treatment of behavioural disturbances in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

A controlled, longitudinal study of dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

An estimate of the prevalence of dementia in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

An estimate of the incidence of dementia in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Frequency of dementia in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Clinical features predicting dementia in idiopathic Parkinson's disease: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

A pilot study of risk factors for dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Risk factors for dementia in Parkinson's disease: effect of education.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Neuropsychological aspects of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Neuropsychological characteristics of preclinical dementia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Neuropsychological prediction of dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The locus ceruleus and dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Cognitive impairments associated with early Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Diagnostic testing for dementia in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Alzheimer's disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Managing the neuropsychiatric symptoms of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Neuropsychological impairment in Parkinson's disease with and without depression

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Risk factors for nursing home placement in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Visual hallucinations associated with Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The Management of the Levodopa Psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Clozapine. A novel antipsychotic agent

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Clozapine prevents recurrence of psychosis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The emerging role of clozapine in the treatment of movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Benztropine versus clozapine for the treatment of tremor in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Worsening of motor features of parkinsonism with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The occurrence of depression in Parkinson's disease. A community-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Depression in Parkinson's disease: a quantitative and qualitative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Effect of age at onset on frequency of depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Depression and disability in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Depression in classic versus akinetic-rigid Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Risk factors for depression in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The correlation of depression with functional activity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The motor performance test series in Parkinson's disease is influenced by depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Cognitive functions in major depression and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Serotonergic dysfunction in depression associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Treatment of depression in Parkinson's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

A survey of antidepressant drug use in Parkinson's disease. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Increase of Parkinson disability after fluoxetine medication

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Internal tremor in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Sertraline for the treatment of depression in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Bupropion in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

ECT and Parkinson's disease revisited: a "naturalistic" study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Anxiety disorders in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Epidemiology and comorbidity of anxiety disorders in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Autonomic failure, depression and anxiety in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Parkinson's disease and anxiety: comorbidity with depression

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The effect of pregnancy in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

The measurement of fatigue: A new instrument

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Fatigue in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Sleep disturbances in Parkinson's disease patients and spouses.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Sleep disorders, pain, and depression in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Sleep in Parkinson's disease. The role of depression and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2800%2900039-0

7 January 2021

10.1016/S1353-8020(00)00039-0

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rk5ma2vkejbuhdsetdtbegsjk4

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_rk5ma2vkejbuhdsetdtbegsjk4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rk5ma2vkejbuhdsetdtbegsjk4

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/rk5ma2vkejbuhdsetdtbegsjk4

1 reference

30 July 2022